iSpecimen Inc. (ISPC) vs Inotiv, Inc. (NOTVQ)

iSpecimen Inc. and Inotiv, Inc. are both Diagnostics & Research companies. iSpecimen Inc. is the larger, with a market value of $3.1M against $2.8M — 1.1× the size. Inotiv, Inc. grew revenue faster over the last twelve months: 5.61% against −92.1%. Inotiv, Inc. has the higher net margin (−17.1% vs −2,449.0%) and the lower return on invested capital (−6.19% vs 0.00%). Across the 19 metrics below, Inotiv, Inc. leads on 10 and iSpecimen Inc. on 9.

Valuation

Metric ISPC NOTVQ Diagnostics & Research median
P/E n/m n/m 33.95
P/S 3.77 0.00 4.87
P/B 1.01 0.00 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA 0.31 60.99 25.20
EV/Sales (5.55) 1.57 5.66
Earnings yield (4,479.37%) (25,300.00%) (1.75%)
Free cash flow yield (617.94%) (2,858.05%) (0.13%)

Profitability

Metric ISPC NOTVQ Diagnostics & Research median
Gross margin (108.26%) 22.94% 50.89%
Operating margin (2,020.05%) (9.48%) (8.57%)
Net margin (2,449.02%) (17.14%) (6.37%)
Free cash flow margin (1,866.61%) (1.95%) 0.00%
Return on equity (968.44%) (74.09%) (2.92%)
Return on assets (170.09%) (11.85%) (6.71%)
Return on invested capital 0.00% (6.19%) 0.00%

Growth

Metric ISPC NOTVQ Diagnostics & Research median
Revenue growth (TTM) (92.11%) 5.61% 7.69%
EPS growth (last fiscal year) 87.03% 49.64% —
Revenue growth, 5-year CAGR (25.10%) 53.36% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ISPC NOTVQ Diagnostics & Research median
Debt to equity 0.00 5.49 0.11
Current ratio 0.82 0.27 2.02
Net debt to EBITDA 0.95 12.68 0.78

Dividend

Metric ISPC NOTVQ Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ISPC NOTVQ Diagnostics & Research median
Market cap 3.12m 2.79m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack